| 标题： | 儿童与青少年新型冠状病毒肺炎管理指南更新 |
| title： | Guidelines for Management of Children and Adolescents with COVID-19: An update |
| 版本： | 更新版 |
| version： | Updated |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 儿童COVID-19防控的儿科医生、临床药师、全科医生和护士等人员 |
| Guide users： | Pediatricians, clinical pharmacists, general practitioners, and nurses in the prevention and control of COVID-19 in children. |
| 证据分级方法： | We will use the GRADE system to rate the evidence. The evidence will be downgraded according to the following five criteria (risk of bias, inconsistency, indirectness, imprecision, and publication bias) or upgraded according to the following three criteria (large magnitude of the effect, dose-response, confounders likely minimize the effect). The final certainty of evidence will be graded as either high, moderate, low, or very low. |
| Evidence grading method： | |
| 制定单位： | 国家儿童健康与疾病临床医学研究中心（重庆医科大学附属儿童医院）；GRADE中国中心；WHO指南实施与知识转化合作中心；亚洲指南联盟 |
| Formulating unit： | The China National Clinical Research Center for Children Health and Disease (Children’s Hospital of Chongqing Medical University); G-I-N Asia; Chinese GRADE Center; WHO Collaborating Centre for Guideline Implementation and Knowledge Translation |
| 注册时间： | 2020-07-27 |
| Registration time： | |
| 注册编号： | IPGRP-2020CN101 |
| Registration number： | |
| 指南制订的目的： | 自新型冠状病毒肺炎（COVID-19）爆发以来，时刻威胁着人们的生命安全，给全球公共卫生与医疗服务体系带来了巨大的挑战。为了确保指南推荐意见的时效性和可靠性，《国际儿童新型冠状病毒管理快速建议指南》工作组启动该指南的更新过程，为后疫情时代儿童与青少年COVID-19的管理提供实际指导 |
| Purpose of the guideline： | Since the outbreak of COVID-19, it has become a life-threatening disease that poses a significant challenge to public health and health care systems worldwide. To ensure the timeliness and reliability of the guideline recommendations, the Working Group on Rapid advice guidelines for the management of children with COVID-19 initiated a process to update the guideline to provide practical guidance for the management of COVID-19 in children and adolescents in the post-epidemic era. |
